A detailed history of Allworth Financial LP transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Allworth Financial LP holds 96 shares of RVMD stock, worth $5,292. This represents 0.0% of its overall portfolio holdings.

Number of Shares
96
Previous 111 13.51%
Holding current value
$5,292
Previous $4,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$36.92 - $47.94 $553 - $719
-15 Reduced 13.51%
96 $4,000
Q2 2024

Jul 23, 2024

BUY
$30.14 - $40.68 $3,345 - $4,515
111 New
111 $4,000
Q3 2023

Oct 31, 2023

BUY
$25.17 - $35.05 $880 - $1,226
35 New
35 $0
Q1 2022

Apr 22, 2022

BUY
$17.31 - $26.4 $190 - $290
11 New
11 $0
Q4 2021

Jan 21, 2022

SELL
$24.35 - $33.7 $2,435 - $3,370
-100 Closed
0 $0
Q3 2020

Nov 03, 2020

BUY
$22.61 - $34.8 $2,261 - $3,479
100 New
100 $3,000

Others Institutions Holding RVMD

About Revolution Medicines, Inc.


  • Ticker RVMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,697,600
  • Market Cap $4.83B
  • Description
  • Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...
More about RVMD
Track This Portfolio

Track Allworth Financial LP Portfolio

Follow Allworth Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allworth Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Allworth Financial LP with notifications on news.